Alectinib-Induced Pleural and Pericardial Effusions in ALK-Positive NSCLC

por Ulhoi, Maiken Parm, Sorensen, Boe Sandahl, Meldgaard, Peter
Publicado 2021

Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer

por Stensgaard, Simone, Thomsen, Astrid, Helstrup, Sofie, Meldgaard, Peter, Sorensen, Boe S.
Publicado 2023

Tumoral PD-L1 does not impact time to treatment discontinuation in EGFR mutated non-small cell lung cancer patients treated with EGFR tyrosine kinase inhibitor—a Danish cohort stud...

por Dissing, Julie Gabe, Ulhøi, Maiken Parm, Sorensen, Boe Sandahl, Meldgaard, Peter
Publicado 2022

Day-to-day and within-day biological variation of cell-free DNA

por Madsen, Anne Tranberg, Hojbjerg, Johanne Andersen, Sorensen, Boe Sandahl, Winther-Larsen, Anne
Publicado 2019

Epithelial-to-mesenchymal transition is a resistance mechanism to sequential MET-TKI treatment of MET-amplified EGFR-TKI resistant non-small cell lung cancer cells

por Clement, Michelle Simone, Gammelgaard, Kristine Raaby, Nielsen, Anders Lade, Sorensen, Boe Sandahl
Publicado 2020

Circulating immune response proteins predict the outcome following disease progression of osimertinib treated epidermal growth factor receptor-positive non-small cell lung cancer p...

por Maansson, Christoffer T., Helstrup, Sofie, Ebert, Eva B. F., Meldgaard, Peter, Sorensen, Boe S.
Publicado 2023

Cell‐free chromatin immunoprecipitation can determine tumor gene expression in lung cancer patients

por Trier Maansson, Christoffer, Meldgaard, Peter, Stougaard, Magnus, Nielsen, Anders Lade, Sorensen, Boe Sandahl
Publicado 2023

Expression of PIK3CA, PTEN mRNA and PIK3CA mutations in primary breast cancer: association with lymph node metastases

por Palimaru, Irina, Brügmann, Anja, Wium-Andersen, Marie Kim, Nexo, Ebba, Sorensen, Boe Sandahl
Publicado 2013

Gene Expression of the EGF System—a Prognostic Model in Non–Small Cell Lung Cancer Patients Without Activating EGFR Mutations()

por Sandfeld-Paulsen, Birgitte, Folkersen, Birgitte Holst, Rasmussen, Torben Riis, Meldgaard, Peter, Sorensen, Boe S.
Publicado 2016

A method for treatment monitoring using circulating tumour DNA in cancer patients without targetable mutations

por Demuth, Christina, Winther-Larsen, Anne, Madsen, Anne Tranberg, Meldgaard, Peter, Sorensen, Boe Sandahl
Publicado 2018

DNAfusion: an R/Bioconductor package for increased sensitivity of detecting gene fusions in liquid biopsies

por Maansson, Christoffer Trier, Andersen, Emma Roger, Ulhoi, Maiken Parm, Meldgaard, Peter, Sorensen, Boe Sandahl
Publicado 2023

Expression of the EGF Family in Gastric Cancer: Downregulation of HER4 and Its Activating Ligand NRG4

por Nielsen, Trine Ostergaard, Friis-Hansen, Lennart, Poulsen, Steen Seier, Federspiel, Birgitte, Sorensen, Boe Sandahl
Publicado 2014

Monitoring of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Sensitizing and Resistance Mutations in the Plasma DNA of Patients With Advanced Non–Small Cell Lung Cancer...

por Sorensen, Boe S, Wu, Lin, Wei, Wen, Tsai, Julie, Weber, Britta, Nexo, Ebba, Meldgaard, Peter
Publicado 2014

Exosomal proteins as potential diagnostic markers in advanced non-small cell lung carcinoma

por Jakobsen, Kristine R., Paulsen, Birgitte S., Bæk, Rikke, Varming, Kim, Sorensen, Boe S., Jørgensen, Malene M.
Publicado 2015

Dasatinib and Doxorubicin Treatment of Sarcoma Initiating Cells: A Possible New Treatment Strategy

por Aggerholm-Pedersen, Ninna, Demuth, Christina, Safwat, Akmal, Meldgaard, Peter, Kassem, Moustapha, Sandahl Sorensen, Boe
Publicado 2016

Early Change in FDG-PET Signal and Plasma Cell-Free DNA Level Predicts Erlotinib Response in EGFR Wild-Type NSCLC Patients()

por Winther-Larsen, Anne, Fledelius, Joan, Demuth, Christina, Bylov, Catharina M, Meldgaard, Peter, Sorensen, Boe S
Publicado 2016

Increased PD-L1 expression in erlotinib-resistant NSCLC cells with MET gene amplification is reversed upon MET-TKI treatment

por Demuth, Christina, Andersen, Morten Nørgaard, Jakobsen, Kristine Raaby, Madsen, Anne Tranberg, Sørensen, Boe Sandahl
Publicado 2017

The T790M resistance mutation in EGFR is only found in cfDNA from erlotinib-treated NSCLC patients that harbored an activating EGFR mutation before treatment

por Demuth, Christina, Madsen, Anne Tranberg, Weber, Britta, Wu, Lin, Meldgaard, Peter, Sorensen, Boe Sandahl
Publicado 2018

Genomic Profiling of Circulating Tumor DNA Predicts Outcome and Demonstrates Tumor Evolution in ALK-Positive Non-Small Cell Lung Cancer Patients

por Madsen, Anne Tranberg, Winther-Larsen, Anne, McCulloch, Tine, Meldgaard, Peter, Sorensen, Boe Sandahl
Publicado 2020

EGFR transcription in non‐small‐cell lung cancer tumours can be revealed in ctDNA by cell‐free chromatin immunoprecipitation (cfChIP)

por Månsson, Christoffer Trier, Vad‐Nielsen, Johan, Meldgaard, Peter, Nielsen, Anders Lade, Sorensen, Boe Sandahl
Publicado 2021